Monday, August 14, 2017 8:36:59 AM
BTX - 2.61
BioTime Wins $2 Mln Grant for Continued Development of Age-Related Macular Degeneration Treatment
BioTime Wins $2 Mln Grant for Continued Development of Age-Related Macular Degeneration Treatment
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
